运用天主教社会教导(CST)关于资本主义的道德原则,分配正义,私有制,共同利益,以及国家在经济中的作用,作为整体理论框架,利用二次数据,媒体报道,和科学文献,本文探讨了顶级制药商在其基本药物和COVID-19疫苗的所有权和定价方面的企业道德责任。具体来说,它介绍了吉利德科学公司的商业战略和Remdesivir药物的定价过高的情况,以说明掠夺性资本主义如何破坏药物制造商的道德责任和CST在当今大流行中对共同利益的道德原则。分配正义要求公共资助和开发的药物和疫苗应公平定价和分配,以促进共同利益,并防止公众为这些基本药物“支付两倍”。鉴于这些药物的公共性质和社会正义的要求,Remdesivir和吉利德科学公司和大型制药公司的其他基本药物对COVID-19的价格可能低于官方宣布的价格。最终,根据CST关于分配正义的理论,这些药物本可以成为全球公共卫生产品,共同利益,以及私有制的社会层面。
Applying the moral principles of Catholic social teaching\'s (CST) on
capitalism, distributive justice, private ownership, the common good, and the role of the state in the economy as the overall theoretical framework and utilizing secondary data, media
reports, and scientific literature, this article explores the corporate moral responsibility of the top drug makers in the ownership and pricing of their essential medicines and COVID-19 vaccines. Specifically, it presents the
case of the Gilead Sciences\' business strategies and overpricing of Remdesivir drug to illustrate how predatory
capitalism undermines the moral responsibility of drug makers and CST\'s moral principle on the common good in today\'s pandemic. Distributive justice requires that the publicly funded and developed medicines and vaccines should be priced and distributed fairly to promote the common good and prevent the public from \"paying twice\" for these essential medicines. Given the public character of these medicines and the demands of social justice, the price of Remdesivir and other essential medicines of Gilead Sciences and Big Pharma for COVID-19 could have been lower than what was officially announced. Ultimately, these medicines could have been made global public health goods in accordance with CST\'s doctrines on distributive justice, the common good, and the social dimension of private ownership.